Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03174678
Other study ID # 2017/1080
Secondary ID
Status Completed
Phase Phase 4
First received May 28, 2017
Last updated June 1, 2017
Start date March 1, 2017
Est. completion date May 25, 2017

Study information

Verified date May 2017
Source Adnan Menderes University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this retrospective study was to detect the effectiveness of 1µg/kg oral dexmedetomidine premedication on preoperative cooperation and emergence delirium of the the young children underwent complete dental treatment.


Description:

One Hundred children between the ages 2-6 years of ASA I status underwent full mouth dental rehabilitation were enrolled in the study. Group Dex (n=50) received 1µg/kg dexmedetomidine in apple juice and Group control (n=50) received apple juice only. Patients' Ramsey Sedation Scale (RSS), The Parental Seperation Anxiety Scale (PSAS), Mask Acceptance Scale (MAS) and Post anesthesia emergence delirium scale (PAEDS) and hemodynamic parameters were noted from their patient file. Premedication period was 45 minutes and measurements of RSS and hemodynamic parameters were recorded in baseline and every 15 minutes until the patients were transferred to the operating room. The data were analysed using the Kruskal-Wallis test, two sample t- tests, chi-square tests and ANOVA.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date May 25, 2017
Est. primary completion date May 1, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 6 Years
Eligibility Inclusion Criteria:

- The inclusion criteria is age between 2 to 6 years and American Society og Anesthesiology (ASA) grade 1.

Exclusion Criteria:

- The exclusion criteria included congenital disease, DEX, propofol allergy, asthma, mental retardation and those children parents refuse to participate study.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dexmedetomidine
1µg/kg dexmedetomidine oral
Other:
apple juice
apple juice

Locations

Country Name City State
Turkey Sultan Keles Aydin Efeler

Sponsors (1)

Lead Sponsor Collaborator
Adnan Menderes University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Kumari S, Agrawal N, Usha G, Talwar V, Gupta P. Comparison of Oral Clonidine, Oral Dexmedetomidine, and Oral Midazolam for Premedication in Pediatric Patients Undergoing Elective Surgery. Anesth Essays Res. 2017 Jan-Mar;11(1):185-191. doi: 10.4103/0259-1162.194586. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Mask Acceptance Score Mask acceptance Before induction
Primary Ramsey Sedation Score Sedation level 45 minutes after premedication
Secondary Parental Separation Anxiety Score Separation anxiety preoperative
See also
  Status Clinical Trial Phase
Completed NCT02265822 - Melatonin Premedication in Children Undergoing Surgery Phase 4
Completed NCT05604599 - Intranasal Versus Intravenous Dexmedetomidine for Hypotensive Anesthesia in FESS Phase 4
Completed NCT03357718 - Oral Dexmedetomidine vs Midazoam For Premedication Phase 4
Completed NCT01490580 - Premedication Trial for Tracheal Intubation of the NEOnate Phase 2/Phase 3
Completed NCT03603873 - Preoperative Anxiety Level, Premedications and General Anaesthetic Proceedings
Completed NCT02700893 - Cerebral NIRS Profiles During Premedication for Neonatal Intubation Phase 2/Phase 3
Completed NCT05946928 - EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY
Completed NCT03325335 - Assessing the Effectiveness of Midazolam Premedication N/A
Completed NCT02072083 - Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients Phase 4